In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...

Get the detailed quarterly/annual income statement for Recursion Pharmaceuticals, Inc. (RXRX). Find out the revenue, expenses and profit or loss over the last fiscal year.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, JPMorgan raised Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from a Neutral ...

CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, respectively. REC-617, a ...

January 8, 2026: Be sure to use the new Arm Wrestle Simulator code that dropped for Pt.4 of the Christmas update. What are the new Arm Wrestle Simulator codes? This popular Roblox experience channels ...

Abstract: Musculoskeletal biomechanics simulation is crucial for evaluating the risk of muscle fatigue and joint injuries among manual handling workers caused by high-intensity repetitive upper limb ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

This project simulates large-scale production environments—factories, mines, storage units, waste facilities, and drone logistics—using a configurable, cycle-based discrete-event engine. It provides ...